Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Moran

Showing results (371-380 of 404) with videos related to

Pageof 41
Sort By:
Journal of the American Chemical Society|June 7, 2021
Turnover and Inactivation Mechanisms for (<i>S</i>)-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine AminotransferaseSida Shen, Arseniy Butrin, Peter F Doubleday, et al.
Journal of Cardiovascular Pharmacology|July 1, 1983
Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitorE J Sybertz, T Baum, H S Ahn, et al.
British Journal of Anaesthesia|October 20, 2018
Propofol-induced unresponsiveness is associated with impaired feedforward connectivity in cortical hierarchyR D Sanders, M I Banks, M Darracq, et al.
Implementation Science Communications|November 25, 2025
Leveraging community engagement and human-centered design to develop multilevel implementation strategies to enhance adoption of a health equity interventionMaggi A Price, Patrick J Mulkern, Madelaine Condon, et al.
Research Square|April 8, 2025
Leveraging Community Engagement and Human-Centered Design to Develop Multilevel Implementation Strategies to Enhance Adoption of a Health Equity InterventionMaggi A Price, Patrick J Mulkern, Madelaine Condon, et al.
Archives of General Psychiatry|January 6, 2010
Structural differences in adult orbital and ventromedial prefrontal cortex predicted by infant temperament at 4 months of ageCarl E Schwartz, Pratap S Kunwar, Douglas N Greve, et al.
ACS Chemical Biology|April 17, 2024
Design, Synthesis, and Mechanistic Studies of (<i>R</i>)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine AminotransferaseAllison N Devitt, Abigail L Vargas, Wei Zhu, et al.
ACS Chemical Biology|July 18, 2024
Correction to "Design, Synthesis, and Mechanistic Studies of (<i>R</i>)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase"Allison N Devitt, Abigail L Vargas, Wei Zhu, et al.
Journal of the American Chemical Society|March 16, 2022
Rational Design, Synthesis, and Mechanism of (3<i>S</i>,4<i>R</i>)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA AminotransferaseWei Zhu, Arseniy Butrin, Rafael D Melani, et al.
Journal of the American Chemical Society|April 19, 2023
Correction to "Rational Design, Synthesis, and Mechanism of (3<i>S</i>,4<i>R</i>)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA Aminotransferase"Wei Zhu, Arseniy Butrin, Rafael D Melani, et al.
Pageof 41

Showing results (371-380 of 404) with videos related to

Sort By:
Pageof 41
Journal of the American Chemical Society|June 7, 2021
Turnover and Inactivation Mechanisms for (<i>S</i>)-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine AminotransferaseSida Shen, Arseniy Butrin, Peter F Doubleday, et al.
Journal of Cardiovascular Pharmacology|July 1, 1983
Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitorE J Sybertz, T Baum, H S Ahn, et al.
British Journal of Anaesthesia|October 20, 2018
Propofol-induced unresponsiveness is associated with impaired feedforward connectivity in cortical hierarchyR D Sanders, M I Banks, M Darracq, et al.
Implementation Science Communications|November 25, 2025
Leveraging community engagement and human-centered design to develop multilevel implementation strategies to enhance adoption of a health equity interventionMaggi A Price, Patrick J Mulkern, Madelaine Condon, et al.
Research Square|April 8, 2025
Leveraging Community Engagement and Human-Centered Design to Develop Multilevel Implementation Strategies to Enhance Adoption of a Health Equity InterventionMaggi A Price, Patrick J Mulkern, Madelaine Condon, et al.
Archives of General Psychiatry|January 6, 2010
Structural differences in adult orbital and ventromedial prefrontal cortex predicted by infant temperament at 4 months of ageCarl E Schwartz, Pratap S Kunwar, Douglas N Greve, et al.
ACS Chemical Biology|April 17, 2024
Design, Synthesis, and Mechanistic Studies of (<i>R</i>)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine AminotransferaseAllison N Devitt, Abigail L Vargas, Wei Zhu, et al.
ACS Chemical Biology|July 18, 2024
Correction to "Design, Synthesis, and Mechanistic Studies of (<i>R</i>)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase"Allison N Devitt, Abigail L Vargas, Wei Zhu, et al.
Journal of the American Chemical Society|March 16, 2022
Rational Design, Synthesis, and Mechanism of (3<i>S</i>,4<i>R</i>)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA AminotransferaseWei Zhu, Arseniy Butrin, Rafael D Melani, et al.
Journal of the American Chemical Society|April 19, 2023
Correction to "Rational Design, Synthesis, and Mechanism of (3<i>S</i>,4<i>R</i>)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA Aminotransferase"Wei Zhu, Arseniy Butrin, Rafael D Melani, et al.
Pageof 41